Neuroprotective/Neurotrophic Effect of Lexapro in Patients With Posttraumatic Stress Disorder.

Trial Profile

Neuroprotective/Neurotrophic Effect of Lexapro in Patients With Posttraumatic Stress Disorder.

Recruiting
Phase of Trial: Phase II

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Escitalopram (Primary)
  • Indications Post-traumatic stress disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Jun 2012 Planned End Date changed from 1 Jun 2011 to 1 Feb 2014 as reported by ClinicalTrials.gov.
    • 10 Jan 2011 Planned End Date changed from 1 Nov 2010 to 1 Jun 2011 as reported by ClinicalTrials.gov.
    • 11 Nov 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top